Aplicações práticas de uma plataforma multiplex para detecção de IgE específica por componentes alergênicos em doenças alérgicas
Practical applications of a multiplex platform for specific IgE detection based on allergenic components in allergic diseases
Resumo
As doenças alérgicas destacam-se entre as principais doenças crônicas não transmissíveis das últimas décadas. O avanço da biologia molecular, por sua vez, permite melhor compreensão sobre os mecanismos envolvidos na fisiopatologia das doenças, e consequente aprimoramento no diagnóstico. A identificação de componentes alergênicos específicos, recombinantes ou purificados, possibilita um conhecimento mais específico do perfil de sensibilização do paciente alérgico, inferindo informações relevantes na investigação de alergias mediadas por IgE. Paralelamente, a utilização de plataformas multiplex viabiliza a detecção simultânea de dezenas de componentes alergênicos, otimizando a investigação de pacientes polissensibilizados. A compreensão de instrumentos laboratoriais que permitam detectar a presença de IgE, suas vantagens, desvantagens e aplicabilidade clínica são fundamentais para melhor controle do paciente alérgico e manejo terapêutico. Esta revisão tem como objetivo descrever os principais dados publicados sobre o papel das plataformas multiplex (ImmunoCAP ISAC®) em diferentes situações clínicas relacionadas a doenças alérgicas.
Palavras-chave
Abstract
Allergic diseases have been among the most common chronic non-communicable diseases over the past decades. Advances in the field of molecular biology, in turn, have allowed to better understand the mechanisms involved in the pathophysiology of allergic diseases and thus improve diagnosis. The identification of specific recombinant or purified protein components enables a deeper knowledge of the sensitization profile of allergic patients, suggesting relevant information when screening for IgE-mediated allergy. In the meantime, multiplex platforms allow simultaneous detection of several protein components, optimizing the investigation of polysensitized patients. Understanding laboratory tools that are able to detect the presence of IgE, their advantages, disadvantages and clinical applicability, is paramount to improve symptom control and therapeutic management in allergic patients. In this review, we aimed to describe the main data available on the role of multiplex platforms (ImmunoCAP ISAC®) in different allergy-related clinical situations.
Keywords
Referências
1. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy. 1999;29:896‑904.
2. Willumsen N, Holm J, Christensen LH, Würtzen PA, Lund K. The complexity of allergic patients’ IgE repertoire correlates with serum concentration of allergen-specific IgE. Clin Exp Allergy. 2012;42(8):1227-36.
3. Mari A. When does a protein become na allergen? Searching for a dynamic definition based on most advanced technology tools. Clin Exp Allergy. 2008;38:1089-94.
4. Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.
5. Liu AH, Martinez FD. Natural History of Allergic Diseases and Asthma. In: Leung DYM, et al. Pediatric Allergy: Principles and Practice. 3ª ed. New York: Elsevier. p:7-17.
6. Oettgen HC. Regulation and Biology of Immunoglobulin E. In: Leung DYM et al. Pediatric Allergy: Pediatric Allergy: Principles and Practice. 3ª ed. New York: Elsevier. p. 31-40.
7. Blank U, Falcone FH, Nilsson G. The history of mast cell and basophil research - some lessons learnt from the last century. Allergy. 2013;68:1093-101.
8. Williams KW, Milner JD, Freeman, AF. Eosinophilia associated with disorders of immune deficiency or immune dysregulation. Immunol Allergy Clin North Am. 2015;35(3):523-44.
9. Hamilton RG. Laboratory Diagnosis of Human Allergic Disease. In: Leung DYM, et al. Pediatric Allergy: Principles and Practice. 3ª ed. New York: Elsevier. p.167-76.
10. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI molecular allergology user's guide. Pediatr Allergy Immunol. 2016;27:Suppl 23:1-250.
11. Patelis A, Borres MP, Kober A, Berthold M. Multiplex componentbased allergen microarray in recent clinical studies. Clinical & Experimental Allergy. 2016;46:1022-32.
12. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133(2):291-307.
13. Santos AF, Brough HA. Making the most of in vitro tests to diagnose food allergy. J Allergy Clin Immunol Pract. 2017;5(2):237-48.
14. Moreno FJ, Clemente A. 2S Albumin storage proteins: what makes them food allergens? The Open Biochemistry Journal. 2008;2:16‑28.
15. Asero R, Mistrello G, Roncarolo D, Amato S, Zanoni D, Barocci F, Caldironi G. Detection of clinical markers of sensitization to profilin in patients allergic to plant-derived foods. J Allergy Clin Immunol. 2003;112:427-32.
16. Breiteneder H, Radauer C. A classification of plant food allergens. J Allergy Clin Immunol. 2004;113:821-30.
17. Fernandez-Rivas M, Cuevas M. Peels of Rosaceae fruits have a higher allergenicity than pulps. Clin Exp Allergy. 1999;29:1239‑47.
18. Zuidmeer L, van Ree R. Lipid transfer protein allergy: primary food allergy or pollen/food syndrome in some cases. Curr Opin Allergy Clin Immunol. 2007;7:269-73.
19. González-Cervera J, Lucendo AJ. Eosinophilic esophagitis: an evidence-based approach to therapy. J Investig Allergol Clin Immunol. 2016;26(1):8-18.
20. Armentia A, Martin S, Barrio J, Martin B, Garcia JC, Veja JM, et al. Value of microarray allergen assay in the management of eosinophilic oesophagitis. Allergologia et Immunopathologia. 2015;43(1):73‑80.
21. Van Rhujn BD, Vlieg-Boerstra BJ, Versteeg AS, Akkerdaas JH, Van Ree R, Terreehorst I, et al. J Allergy Clin Immunol. 2015;136(4):1095-6.
22. Balmer-Weber BK. Value of allergy tests for the diagnosis of food allergy. Dig Dis. 2014;32:84-8.
23. Boguniewicz M, Leung DYM. Atopic Dermatitis. In: Middleton’s Allergy Principles and Practice. 8ª ed. Philadelphia: Elsevier; 2014. Cap. 34.
24. Campana R, Dzoro S, Mittermann I, Fedenko E, Elisyutina O, Khaitov M, Valenta R. Molecular aspects of allergens in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2017;17:269-77.
25. Ott H, Weibmantel S, Kennes LN, Merk HF, Baron JM, Folster-Holst R. Molecular microarray analysis reveals allergen - and exotoxinspecific IgE repertoires in children with atopic dermatitis. JEADV. 2014;28:100-7.
26. D'Auria E, Banderali G, Barberi S, Gualandri L, Pietra B, Riva E, Cerri A. Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target. Asian Pac J Allergy Immunol. 2016;34:98-108.
27. Eller E, Kjaer HF, Høst A, et al. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy. 2009;64(7):1023-9.
28. Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE mediated food allergy among children with atopic dermatitis. Pediatrics. 1998;101(3):E8.
29. Manam S, Tsakok T, Till S, and Flohr C. The association between atopic dermatitis and food allergy in adults. Curr Opin Allergy Clin Immunol. 2014;14:423-9.
30. Caubet JC, Nowak-Węgrzyn. Atopic dermatites in infants and young children. In: Sampson HA. Mount Sinai Expert Guides. New York: Wiley Blackwell; 2015. Cap.1
31. Cox L, Calderon MA. Allergen Immunotherapy for atopic dermatitis: is there room for debate? J Allergy Clin Immunol Pract. 2016;4(3):435‑44.
32. Spergel JM, Boguniewicz M, Schneider L, Hanifin JM, Paller AS. Food allergy in infants with atopic dermatitis: limitations of foodspecific ige measurements. Pediatrics. 2015;136(6):e1530-8.
33. de Bruin Weller MS, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Evaluation of the child with atopic dermatitis. Clin Exp Allergy. 2012;42(3):352-62.
34. Fedenko E, Elisyutina O, Shtyrbul O, Pampura A, Valenta R, Lupinek C, et al. Microarray-based IgE serology improves management of severe atopic dermatitis in two children. Ped Allergy Immunol. 2016;27(6):645-9.
35. Breuer K, Heratizadeh A, Wulf A, Baumann U, Constien A, Tetau D, et al. Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy. 2004;34:817-24.
36. Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rance F, Turjanmaa K, et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy. 2007;62:723-8.
37. Gray CL, Levin ML, Toit G. Egg sensitization, allergy and component patterns in African children with atopic dermatitis. Pediatric Allergy and Immunology. 2016;27(7):709-15.
38. Fung I, Kim JS, Spergel JM. Relating microarray component testing and reported food allergy and food-triggered atopic dermatitis: a realworld analysis. Ann Allergy Asthma Immunol. 2013;110:173-7.
39. Foong RX, Roberts G, Fox AT, du Toit G. Pilot study: assessing the clinical diagnosis of allergy in atopic children using a microarray assay in addition to skin prick testing and serum specific IgE. Clin Mol Allergy. 2016;14:8-14.
40. Lombardi C, Savi E, Ridolo E, Passalacqua G, Canonica GW. Is allergic sensitization relevant in severe asthma? Which allergens may be culprit? World Allergy Organ J. 2017;10:2.
41. Global Initiative for asthma. Global strategy for asthma management and prevention, 2017. Disponível em: www.ginasthma.org.
42. Konradsen JR, Nordlund B, Onell A, Borres MP, Gr onlund H, Hedlin G. Severe childhood asthma and allergy to furry animals: Refined assessment using molecular-based allergy diagnostics. Pediatr Allergy Immunol. 2014;25:187-92.
43. Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr Allergy Immunol. 2011;22:454-61.
44. Patelis A, Gunnbjörnsdottir M, Malinovschi A, Matsson P, Onell A, Högman M, et al. Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. J Allergy Clin Immunol. 2012;130:397-402. 45. Önell A, Whiteman A, Nordlund B, Baldracchini F, Mazzoleni G, Hedlin G, et al. Allergy testing in children with persistent asthma: comparison of four diagnostic methods. Allergy. 2017;72:590-7.
46. Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(suppl):S147-334.
47. Giavina-Bianchi P. Defining phenotypes in rhinitis: a step toward personalized medicine. J Allergy Clin Immunol. 2015;135(1):151-2.
48. Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy. 2016;11(9):93-100.
49. Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2011;11(5):471-6.
50. Neto HJ, Rosário NA, Westphal GL, Riedi CA, Santos HL. Allergic conjunctivitis in asthmatic children: as common as underreported. Ann Allergy Asthma Immunol. 2010;105(5):399-400.
51. Geraldini M, Chong Neto HJ, Riedi CA, Rosário NA. Epidemiology of ocular allergy and co-morbidities in adolescents. J Pediatr. 2013;89(4):354-60.
52. Takejima P, Agondi RC, Rodrigues H, Aun MV, Kalil J, GiavinaBianchi P. Allergic and nonallergic asthma have distinct phenotypic and genotypic features. Int Arch Allergy Immunol. 2017;172(3):150‑60.
53. Santosa A, Andiappan AK, Rotzschke O, Wong HC, Chang A, Bigliardi-Qi M, et al. Evaluation of the applicability of the Immunosolid-phase allergen chip (ISAC) assay in atopic patients in Singapore. Clin Transl Allergy. 2015;27:5-9.
54. Jung JH, Kang IG, Kim ST. Comparison of component-resolved diagnosis by using allergen microarray with the conventional tests in allergic rhinitis patients: the first using in Korea. Clin Exp Otorhinolaryngol. 2015;8(4):385-9.
55. Prosperi MC, Belgrave D, Buchan I, Simpson A, Custovic A. Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach. Pediatr Allergy Immunol. 2014;25(1):71-9.
56. Bonini M, Marcomini L, Gramiccioni C, Tranquilli C, Melioli G, Canonica GW, et al. Microarray evaluation of specific IgE to allergen components in elite athletes. Allergy. 2012;67(12):1557-64.
57. Araujo LML, Rosário NA, Mari A. Molecular-based diagnosis of respiratory allergic diseases in children from Curitiba, a city in Southern Brazil. Allergol Immunopathol. 2016;44(1):18-22.
58. Bronnert M, Mancini J, Birnbaum J, Agabriel C, Liabeuf V, Porri F, et al. Component-resolved diagnosis with commercially available D. Pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy. 2012;42(9):1406-15.
59. Zeng G, Luo W, Zheng P, Wei N, Huang H, Sun B, Zhao X. ComponentResolved Diagnostic Study of Dermatophagoides Pteronyssinus Major Allergen Molecules in a Southern Chinese Cohort. J Investig Allergol Clin Immunol. 2015;25(5):343-51.
60. Nieto M, Lafuente I, Calderon R, Uixera S, Pina R, Calaforra S, et al. Component-resolved diagnosis: performance of specific IgE to Alternaria compared to Alt a 1. Pediatr Allergy Immunol. 2014;25(8):832-4.
61. Liccardi G, Bilò MB, Manzi F, Piccolo A, Di Maro E, Salzillo A. What could be the role of molecular-based allergy diagnostics in detecting the risk of developing allergic sensitization to furry animals? Eur Ann Allergy Clin Immunol. 2015;47(5):163-7.
62. Asarnoj A, Hamsten C, Wadén K, Lupinek C, Andersson N, Kull I, et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: a BAMSE/MeDALL study. J Allergy Clin Immunol. 2016;137(3):813‑21.
63. Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol. 2012;130:894-901.
64. Westman M, Lupinek C, Bousquet J, Andersson N, Pahr S, Baar A, et al. Early childhood IgE reactivity to pathogenesis-related class
10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol. 2015;135:1199-206.
Submetido em:
24/09/2017
Aceito em:
10/02/2018
